Circulating tumor (ct)DNA monitoring of ER+/HER2- high-risk breast cancer during adjuvant endocrine therapy

Puzstai L, Scalise CB, Kalashnikova E, et al. Oral presentation presented at ASCO Annual Meeting 2025, Chicago, IL. May 30 - June 3, 2025.